Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study-Reference-Cited by-同舟云学术

Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study

Published:2022-07 Issue:7 Volume:32 Page:1670-1680
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Cui Kongyong^ORCID,Yin Dong,Zhu Chenggang,Yuan Sheng,Wu Shaoyu,Feng Lei,Dou Kefei^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference39 articles.

1. Use of Lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association;Wilson;J Clin Lipidol,2019

2. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies;Tsimikas;J Am Coll Cardiol,2017

3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

4. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study;Kamstrup;Circulation,2008

5. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies;Danesh;Circulation,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Elevated Lipoprotein A on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis;Cureus;2024-05-25

2. Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease;Annals of Cardiac Anaesthesia;2024-01

3. Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations;Cardiology Journal;2023-10-16

4. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes;Journal of Endocrinological Investigation;2023-09-30

5. Lipoprotein(a) is a new prognostic factor in patients with psoriasis and coronary artery disease: a retrospective cohort study;Lipids in Health and Disease;2023-09-02